Cel-Sci
CVM
#9861
Rank
NZ$74.39 M
Marketcap
NZ$8.85
Share price
-0.97%
Change (1 day)
-59.69%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -NZ$41.89 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$46.27 Million, an increase over its 2023 earnings that were of -NZ$52.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$41.89 Million-9.47%
2024 -NZ$46.27 Million-12.41%
2023 -NZ$52.82 Million-12.87%
2022 -NZ$60.63 Million-3.42%
2021 -NZ$62.78 Million13.44%
2020 -NZ$55.34 Million11.28%
2019 -NZ$49.73 Million179.81%
2018 -NZ$17.78 Million-48.72%
2017 -NZ$34.66 Million-16.23%
2016 -NZ$41.37 Million-23.63%
2015 -NZ$54.18 Million-5.47%
2014 -NZ$57.31 Million198.49%
2013 -NZ$19.2 Million
2010 -NZ$22.41 Million
2004 -NZ$7.58 Million12.38%
2003 -NZ$6.74 Million-16.59%
2002 -NZ$8.08 Million-59.28%
2001 -NZ$19.85 Million23.17%
2000 -NZ$16.11 Million20.12%
1999 -NZ$13.41 Million13.24%
1998 -NZ$11.85 Million-20%
1997 -NZ$14.81 Million46.55%
1996 -NZ$10.11 Million34.88%
1995 -NZ$7.49 Million2.38%
1994 -NZ$7.32 Million68%
1993 -NZ$4.36 Million78.57%
1992 -NZ$2.44 Million180%
1991 -NZ$0.88 Million25%
1990 -NZ$0.7 Million-0%
1989 -NZ$0.7 Million-71.43%
1988 -NZ$2.44 Million-0%
1987 -NZ$2.44 Million-46.15%
1986 -NZ$4.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-NZ$56.7 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$11.53 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.35 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-NZ$0.25 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.08 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
NZ$56.41 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$16.53 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA